Cargando…
Survey-reported medication changes among older adults during the SARS-CoV-2 (COVID-19) pandemic
BACKGROUND: Speculation on benefits and harms of prescription, over-the-counter and complementary medications has been widespread during the SARS-CoV-2 (or COVID-19) pandemic. This community-based survey assessed self-reported changes in medications including those stopped, started, or if access had...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659512/ https://www.ncbi.nlm.nih.gov/pubmed/33221267 http://dx.doi.org/10.1016/j.sapharm.2020.11.005 |
_version_ | 1783608837564006400 |
---|---|
author | Brown, Joshua D. Vouri, Scott M. Manini, Todd M. |
author_facet | Brown, Joshua D. Vouri, Scott M. Manini, Todd M. |
author_sort | Brown, Joshua D. |
collection | PubMed |
description | BACKGROUND: Speculation on benefits and harms of prescription, over-the-counter and complementary medications has been widespread during the SARS-CoV-2 (or COVID-19) pandemic. This community-based survey assessed self-reported changes in medications including those stopped, started, or if access had been impacted. METHODS: A survey was collected via Research Electronic Data Capture (REDCap). The survey was advertised in the community through social media, email lists, websites, and post-cards. Survey responses were collected between 5/21/2020 and 6/24/2020. Variables included demographic characteristics such as age, sex, race, marital status, education, employment, income, and community type. Questions related to medication changes included: “Have you started any medication due to COVID-19?”, “Have you stopped any medication due to COVID-19?” and “Have you had issues getting your prescription medications?”. Respondents aged 50 years or older were included. RESULTS: There were N = 1397 responses of which 1169 were older adults ≥50 years-old. Of these, 1141 responded to the medication changes survey questions and 28 had missing responses and were excluded from the survey sample for this analysis. Among these, 31 (2.7%) reported a medication change included 5 (0.4%) reported stopping a medication, 18 (1.6%) reported starting a medication, and 8 (0.7%) reported trouble obtaining medications. Medications started included mostly vitamins or other supplements including zinc (n = 9), vitamin C (6), and other supplements (3). Among prescription medications, antidepressants and anti-anxiety medications (4) were reported as well as aspirin (1), losartan (1), and low dose naltrexone (1). One respondent reported unidentified homeopathy. There were no significant differences between those with medication changes and those with none. CONCLUSIONS: In this community-based survey sample of over one thousand older adults, only a small percentage (2.7%; n = 31) reported any changes to medications during the pandemic. As essential workers during this crisis, pharmacists have played a critical role in providing medication information and continued access. |
format | Online Article Text |
id | pubmed-7659512 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76595122020-11-13 Survey-reported medication changes among older adults during the SARS-CoV-2 (COVID-19) pandemic Brown, Joshua D. Vouri, Scott M. Manini, Todd M. Res Social Adm Pharm Article BACKGROUND: Speculation on benefits and harms of prescription, over-the-counter and complementary medications has been widespread during the SARS-CoV-2 (or COVID-19) pandemic. This community-based survey assessed self-reported changes in medications including those stopped, started, or if access had been impacted. METHODS: A survey was collected via Research Electronic Data Capture (REDCap). The survey was advertised in the community through social media, email lists, websites, and post-cards. Survey responses were collected between 5/21/2020 and 6/24/2020. Variables included demographic characteristics such as age, sex, race, marital status, education, employment, income, and community type. Questions related to medication changes included: “Have you started any medication due to COVID-19?”, “Have you stopped any medication due to COVID-19?” and “Have you had issues getting your prescription medications?”. Respondents aged 50 years or older were included. RESULTS: There were N = 1397 responses of which 1169 were older adults ≥50 years-old. Of these, 1141 responded to the medication changes survey questions and 28 had missing responses and were excluded from the survey sample for this analysis. Among these, 31 (2.7%) reported a medication change included 5 (0.4%) reported stopping a medication, 18 (1.6%) reported starting a medication, and 8 (0.7%) reported trouble obtaining medications. Medications started included mostly vitamins or other supplements including zinc (n = 9), vitamin C (6), and other supplements (3). Among prescription medications, antidepressants and anti-anxiety medications (4) were reported as well as aspirin (1), losartan (1), and low dose naltrexone (1). One respondent reported unidentified homeopathy. There were no significant differences between those with medication changes and those with none. CONCLUSIONS: In this community-based survey sample of over one thousand older adults, only a small percentage (2.7%; n = 31) reported any changes to medications during the pandemic. As essential workers during this crisis, pharmacists have played a critical role in providing medication information and continued access. Published by Elsevier Inc. 2021-08 2020-11-12 /pmc/articles/PMC7659512/ /pubmed/33221267 http://dx.doi.org/10.1016/j.sapharm.2020.11.005 Text en © 2020 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Brown, Joshua D. Vouri, Scott M. Manini, Todd M. Survey-reported medication changes among older adults during the SARS-CoV-2 (COVID-19) pandemic |
title | Survey-reported medication changes among older adults during the SARS-CoV-2 (COVID-19) pandemic |
title_full | Survey-reported medication changes among older adults during the SARS-CoV-2 (COVID-19) pandemic |
title_fullStr | Survey-reported medication changes among older adults during the SARS-CoV-2 (COVID-19) pandemic |
title_full_unstemmed | Survey-reported medication changes among older adults during the SARS-CoV-2 (COVID-19) pandemic |
title_short | Survey-reported medication changes among older adults during the SARS-CoV-2 (COVID-19) pandemic |
title_sort | survey-reported medication changes among older adults during the sars-cov-2 (covid-19) pandemic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659512/ https://www.ncbi.nlm.nih.gov/pubmed/33221267 http://dx.doi.org/10.1016/j.sapharm.2020.11.005 |
work_keys_str_mv | AT brownjoshuad surveyreportedmedicationchangesamongolderadultsduringthesarscov2covid19pandemic AT vouriscottm surveyreportedmedicationchangesamongolderadultsduringthesarscov2covid19pandemic AT maninitoddm surveyreportedmedicationchangesamongolderadultsduringthesarscov2covid19pandemic |